SUPNSupernus Pharmaceuticals Inc
SUPN
Supernus Pharmaceuticals Inc2,370
Mkt Cap
$2.75BVolume
831,311.0052W High
$59.6852W Low
$29.16PE Ratio
-69.83SUPN Fundamentals
Price
$49.25Prev Close
$47.76Open
$48.8650D MA
$51.14Beta
0.55Avg. Volume
926,103.52EPS (Annual)
-$0.6829P/B
2.58Rev/Employee
$924,102.83$2,537.93
Insider Selling: Supernus Pharmaceuticals (NASDAQ:SUPN) VP Sells 7,250 Shares of Stock
Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN - Get Free Report) VP Padmanabh Bhatt sold 7,250 shares of the business's stock in a transaction that occurred on Wednesday, March 18th. The shares were sold at an average price of $49.60, for a total value of $359,600.00. Following the completion of the...
MarketBeat·5d ago
Supernus Pharmaceuticals (NASDAQ:SUPN) VP Sells $2,514,000.00 in Stock
Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN - Get Free Report) VP Padmanabh Bhatt sold 50,000 shares of Supernus Pharmaceuticals stock in a transaction that occurred on Monday, March 16th. The stock was sold at an average price of $50.28, for a total transaction of $2,514,000.00. Following the...
MarketBeat·5d ago
Supernus Pharmaceuticals (NASDAQ:SUPN) CEO Sells $1,762,950.00 in Stock
Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN - Get Free Report) CEO Jack Khattar sold 35,000 shares of the firm's stock in a transaction that occurred on Friday, March 13th. The stock was sold at an...
MarketBeat·7d ago
Frederick Hudson Sells 5,369 Shares of Supernus Pharmaceuticals (NASDAQ:SUPN) Stock
Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN - Get Free Report) Director Frederick Hudson sold 5,369 shares of the business's stock in a transaction that occurred on Thursday, March 12th. The stock...
MarketBeat·7d ago
Supernus Pharmaceuticals (NASDAQ:SUPN) CEO Jack Khattar Sells 35,000 Shares
Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN - Get Free Report) CEO Jack Khattar sold 35,000 shares of the company's stock in a transaction dated Friday, March 13th. The stock was sold at an average...
MarketBeat·7d ago
Aristotle Capital Boston LLC Sells 503,122 Shares of Supernus Pharmaceuticals, Inc. $SUPN
Aristotle Capital Boston LLC reduced its stake in shares of Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN - Free Report) by 62.2% in the third quarter, according to its most recent 13F filing with the...
MarketBeat·9d ago
Supernus Pharmaceuticals, Inc. $SUPN Shares Acquired by Jefferies Financial Group Inc.
Jefferies Financial Group Inc. increased its stake in Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN - Free Report) by 62.0% in the third quarter, according to its most recent 13F filing with the...
MarketBeat·13d ago
Dimensional Fund Advisors LP Lowers Holdings in Supernus Pharmaceuticals, Inc. $SUPN
Dimensional Fund Advisors LP lowered its position in Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN - Free Report) by 0.6% during the 3rd quarter, according to the company in its most recent disclosure...
MarketBeat·13d ago
Georges Gemayel Sells 8,787 Shares of Supernus Pharmaceuticals (NASDAQ:SUPN) Stock
Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN - Get Free Report) Director Georges Gemayel sold 8,787 shares of the company's stock in a transaction dated Friday, March 6th. The stock was sold at an...
MarketBeat·14d ago
Insider Selling: Supernus Pharmaceuticals (NASDAQ:SUPN) Director Sells 10,000 Shares of Stock
Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN - Get Free Report) Director Georges Gemayel sold 10,000 shares of the firm's stock in a transaction dated Thursday, March 5th. The shares were sold at an...
MarketBeat·14d ago
<
1
2
...
>